Filter by
NewsExpand the synergistic effect of S. boulardii from digestive health to immunityMake the difference and expand the synergistic effect of S. boulardii by combining the probiotic yeast with powerful yeast-based ingredients and documented bacteria strains known to support immunity. Learn more about S. boulardii immunological modes of action and innovative yeast-based based formula in the new leave-behind S. boulardii immune functions The unique probiotic yeast Saccharomyces […]
Dec 10, 2020
NewsOpen access review on probiotics effects on microbiota-gut-brain axis in early-life stress and neuropsychiatric disordersDiscover the latest open access review on “The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders” recently published in Progress in Neuro-Psychopharmacology and Biological Psychiatry. This review explores the published evidence on probiotics, both in preclinical and in clinical studies. It also highlights the challenges associated with conducting longitudinal studies […]
Dec 1, 2020
NewsNew Canadian health claims leading to innovative probiotic applicationsLallemand Health Solutions has gained new indications for its documented Expert’Biotic IBacilluS+ (a combination of probiotic strain Enterococcus faecium Rosell®-26 and Bacillus subtilis Rosell®-179) on Reflux Esophagitis (RE) and Small Intestine Bacterial Overgrowth (SIBO) following proton pump inhibitor (PPI) treatment. IBacilluS+ New Canadian Health Claims • Helps reduce the reappearance of reflux esophagitis symptoms following […]
Nov 23, 2020
NewsNew results showing LACIDOFIL® protects from early-life stress consequencesInfantile stress predisposes individuals to higher anxiety in adulthood. In a new in vivo study, early intake of Lacidofil® (Lallemand Health Solutions proprietary combination of L. rhamnosus Rosell®11 and L. helveticus Rosell®-52) prevented early-life stress consequences in rodents. This is the seventh study documenting various positive effects of this specific probiotic formula in early-life stress. […]
Nov 16, 2020
NewsCEREBIOME® capacity to increase brain-derived neurotrophic factor levels translates from preclinical to clinical studyA new post-hoc analysis confirmed in humans that CEREBIOME® can increase significantly brain-derived neurotrophic factor (BDNF) serum levels as observed several years ago in preclinical models. These new results bring more understanding about the potential modes of action of CEREBIOME® on the gut-brain axis, especially on depressive population. Previously, in 2018, Kazemi et al. followed […]
Oct 20, 2020
NewsThe first psychobiotic in BrazilApsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the brain-gut axis on the Brazilian market, with approved health claims by the Brazilian Health Authorities, ANVISA. Probid and Probians, produced by Lallemand Health Solutions, are available to the Brazilian market since September 2020. […]
Oct 13, 2020
NewsAll together “Running for research” to fund Prader-Willis syndrome researchLallemand Health Solutions is pleased to announce its partnership with Prader-Willi syndrome association (PWS) | USA, and “Running for Research,” a charitable initiative to raise funds for PWS research at the University of Florida. The next run will take place at the Walt Disney World Marathon from January 6 to 10, 2021. Since its founding in 2018, the “Running for Research” team […]
Sep 9, 2020
NewsMeet ROSELLA: A convenient orally administered probiotic shown to support women’s intimate healthLallemand Health Solutions will officially launch ROSELLA, its new highly documented licensed strain for Women’s intimate health at Vitafoods Europe Virtual Expo on September 7 2020. L. plantarum P17630 (Proge P17630®), ROSELLA, licensed from PROGE FARM®, Italy, is a unique strain isolated from a healthy vaginal flora with full mechanistic and clinical evidence of efficacy […]
Sep 1, 2020
NewsLallemand Health Solutions close a major licensing deal with Proge Farm®Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization by Lallemand Health Solutions of Proge Farm®’s established probiotic strain L. plantarum P17630 (Proge P17630®), which has specific women health benefits. “Proge Farm® highly documented probiotic strain L. plantarum P17630 (Proge P17630®), is […]
Jul 17, 2020
NewsLallemand innovative probiotic yeast solutionsAs an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S. boulardii, a time tested yeast mastered and perfected from lab to shelf through a new website and instructive video. S. boulardii by LALLEMAND: CULTURES THAT MATTER Pioneer in formulating probiotic solutions, Lallemand Health […]
Jul 8, 2020